Investors

‘‘ViewRay Systems, Inc.’ established February 6, 2024, after acquisition of all assets of ‘ViewRay, Inc.’ including IP, physical inventory, software, service tools & procedures, QMS, device technical documentation files, production records, etc.

ViewRay Systems, Inc. is a privately held medical device company that designs, manufactures and markets the MRIdian A3i Radiation Therapy System. MRIdian A3i integrates MRI technology, radiation delivery, and our proprietary software to clearly see soft tissue, shape the dose to accommodate for changes in anatomy, and strike the target precisely using real-time targeting throughout the treatment. The MRIdian system is sized to fit into standard radiation therapy vaults without the need to remove ceiling or walls. These capabilities allow MRIdian A3i to deliver radiation to the tumor accurately, while reducing the amount of radiation delivered to nearby healthy tissue, as compared to other radiation therapy treatments currently available. We believe this will lead to improved patient outcomes and reduced treatment-related side effects.